Integrating network analysis and experimental validation to reveal the mechanism of si-jun-zi decoction in the treatment of renal fibrosis
- PMID: 39220912
- PMCID: PMC11365329
- DOI: 10.1016/j.heliyon.2024.e35489
Integrating network analysis and experimental validation to reveal the mechanism of si-jun-zi decoction in the treatment of renal fibrosis
Abstract
Treating kidney diseases from the perspective of spleen is an important clinical method in traditional Chinese medicine (TCM) for anti-renal fibrosis (RF). Si-jun-zi decoction (SJZD), a classic formula for qi-invigorating and spleen-invigorating, has been reported to alleviate RF. This study aims to investigate the potential mechanism by which SJZD attenuates RF. The results demonstrated notable improvements in renal function levels, inflammation and fibrosis indices in UUO-mice following SJZD intervention. The main active ingredients identified were Quercetin, Kaempferol, Naringenin and 7-Methoxy-2-methyl isoflavone. Furthermore, STAT3, MAPK3, MYC were confirmed as key targets. Additionally, GO enrichment analysis demonstrated that SJZD delayed RF primarily by regulating oxidative stress and other biological mechanisms. KEGG enrichment analysis revealed the involvement of pathways such as Lipid and atherosclerosis signaling pathway, MAPK signaling pathway and other pathways in the reno-protective effects of SJZD. The molecular docking results revealed that the active ingredients of SJZD were well-bound and stable to the core targets. The experiments results revealed that Quercetin, Kaempferol, and Naringenin not only improved the morphology of TGF-β-induced HK-2 cells but also reversed the expression of α-SMA, COL1A1 and MAPK, thereby delaying the progression of RF. The anti-RF effects of SJZD were exerted through multi-components, multi-targets and multi-pathways.
Keywords: Experimental validation; Molecular docking; Network pharmacology; Renal fibrosis; Si-jun-zi decoction.
© 2024 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures













Similar articles
-
Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.Front Immunol. 2023 Sep 20;14:1235575. doi: 10.3389/fimmu.2023.1235575. eCollection 2023. Front Immunol. 2023. PMID: 37799727 Free PMC article.
-
Mechanism of Sijunzi Decoction in the treatment of colorectal cancer based on network pharmacology and experimental validation.J Ethnopharmacol. 2023 Feb 10;302(Pt A):115876. doi: 10.1016/j.jep.2022.115876. Epub 2022 Nov 5. J Ethnopharmacol. 2023. PMID: 36343798
-
A Network Pharmacology Approach for Uncovering the Antitumor Effects and Potential Mechanisms of the Sijunzi Decoction for the Treatment of Gastric Cancer.Evid Based Complement Alternat Med. 2022 Apr 12;2022:9364313. doi: 10.1155/2022/9364313. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35463069 Free PMC article.
-
Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of Huanglian Jiedu Decoction against sepsis.Comput Biol Med. 2022 May;144:105389. doi: 10.1016/j.compbiomed.2022.105389. Epub 2022 Mar 9. Comput Biol Med. 2022. PMID: 35303581 Review.
-
Exploration of the mechanism of Zisheng Shenqi decoction against gout arthritis using network pharmacology.Comput Biol Chem. 2021 Feb;90:107358. doi: 10.1016/j.compbiolchem.2020.107358. Epub 2020 Aug 8. Comput Biol Chem. 2021. PMID: 33243703 Review.
Cited by
-
Promotion of Treg/Th17 balance in MRL/lpr mice by Jianpi-Zishen Formula via modulation of DNMT1-mediated Foxp3 methylation.Front Immunol. 2025 Aug 21;16:1631631. doi: 10.3389/fimmu.2025.1631631. eCollection 2025. Front Immunol. 2025. PMID: 40918088 Free PMC article.
References
-
- Lyu P., Bao J., Mou C. Exploration on the origin and clinical significance of master-slave relationship between spleen and kidney by Mou Chong-lin. China. J. Tradit. Chinese. Med. Pharm. 2020;35:3051–3054.
LinkOut - more resources
Full Text Sources
Miscellaneous